Neurogene reaffirms Embolden data for 2H 2027, cash runway into Q1 2029Nov 17M&AAstraZenecaIdexx Laboratories Inc /DeUpdated
Kiora Pharmaceuticals names Keith Lane as EVP of Clinical Development and Regulatory AffairsSep 8PeopleKiora Pharmaceuticals Inc
Kiora licenses South Korean rights to KIO-301 to Chong Kun DangAug 19PartnershipKiora Pharmaceuticals Inc
Kiora reports Q2 2026 results, advances KIO-301 and KIO-104 trialsAug 7Quarterly updateKIO-104Kiora Pharmaceuticals Inc